B. Minihan, E. McAuliffe, J. Powell, S. Wong, K. Wilkie, C. Murphy, A. Maher, L. Power, N. O'Connell, C. Dunne
{"title":"托珠单抗治疗重症监护室高炎症性COVID-19患者与医院获得性细菌和侵袭性真菌感染发生率升高之间的关系","authors":"B. Minihan, E. McAuliffe, J. Powell, S. Wong, K. Wilkie, C. Murphy, A. Maher, L. Power, N. O'Connell, C. Dunne","doi":"10.1016/j.jhin.2022.04.007","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":77413,"journal":{"name":"The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections","volume":"6 4 1","pages":"29 - 36"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"Association between tocilizumab treatment of hyperinflammatory patients with COVID-19 in a critical care setting and elevated incidence of hospital-acquired bacterial and invasive fungal infections\",\"authors\":\"B. Minihan, E. McAuliffe, J. Powell, S. Wong, K. Wilkie, C. Murphy, A. Maher, L. Power, N. O'Connell, C. Dunne\",\"doi\":\"10.1016/j.jhin.2022.04.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":77413,\"journal\":{\"name\":\"The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections\",\"volume\":\"6 4 1\",\"pages\":\"29 - 36\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-04-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jhin.2022.04.007\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Canadian journal of infection control : the official journal of the Community & Hospital Infection Control Association-Canada = Revue canadienne de prevention des infections","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jhin.2022.04.007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Association between tocilizumab treatment of hyperinflammatory patients with COVID-19 in a critical care setting and elevated incidence of hospital-acquired bacterial and invasive fungal infections